Avac Event
June 12 to 14, 2023
The COVID-19 pandemic, the war in Ukraine and other ongoing conflicts in the world, have globally disrupted health services and affected treatment and psychosocial care of people living with HIV.
HIV prevention including HIV testing has also been negatively affected.
In order to ensure that HIV continues to feature on the worldwide agenda, focus and determination will be required.
The theme of the AIDSImpact 2023 is therefore. Power for Action Now!
Avac Event
Join the REACH collaboratory on May 3 from 6:30 to 8:00 PM ET at African Services (427 W 127th St. in Harlem) for a conversation on the importance of engaging diverse populations at every stage of HIV cure research! Food and Drinks Provided from Maison Harlem and doors open at 6:00 PM ET. Help us get the right amount of food by registering in advance!
More info in the flier below:
Avac Event
April 6, 2023, 9:00AM Washington/2:00PM London/4:00PM Nairobi
Over the past two decades, HIV advocates have engaged in hard battles for equitable access to HIV/AIDS drugs and prevention options and have had some big wins. The process of these negotiations has led to strong relationships that have enshrined certain equity provisions as standard in clinical trials and manufacturing of HIV drugs. Through these battles, we’ve learned clear lessons on the necessity for such agreements and what’s required to secure them.
Throughout global PPPR agreements in 2023, governments and advocates in the Global South are asking for provisions on equity in the form of temporary IP waivers, mandatory tech transfer, and mandatory licensing for pandemic tools.
This panel will discuss lessons from the HIV epidemic and explore why governments of the Global South and advocates think we still need to address ‘the IP question’.
Featured Speakers: Fifa Rahman, Brook Baker, Fitsum Lakew, and Esteban Burrone
Avac Event
Summary of the Global Fund investment case, and the recently released Results Report for 2022, which features information on the number of lives saved and the impact of $18 billion in spending.
Avac Event
PEP, post-exposure-prophylaxis, is an HIV prevention intervention marked by both great promise and profound neglect. It is useful in both occupational and non-occupational contexts—yet uptake, especially in non-occupational contexts—is poor in most places on the planet. Our panel unpacked the issues and offered research, policy, and programming ideas to address PEP neglect and realize its potential.
Speakers
Avac Event
Very high STI prevalence is being observed globally. Doxycycline post-exposure prophylaxis (dPEP) has been proposed as an STI prevention strategy to reduce chlamydia, syphilis, and possibly gonorrhea, and trials are ongoing among cisgender gay and bisexual men as well as African cisgender women. Join us to hear the latest scientific data and discuss implications for policy and program.
Speakers:
Avac Event
Lessons from family planning (FP) for the introduction of multi-purpose prevention technologies (MPTs)
The Dual Prevention Pill (DPP) is a daily pill being developed for simultaneous pregnancy and HIV prevention. With anticipated rollout of the DPP just two years away, planning for where to introduce the DPP in the private sector will be critical for ensuring access, but will hinge on where PrEP delivery is already permitted.
In this webinar, we shared new findings on private sector opportunities for the DPP in Kenya, South Africa and Zimbabwe. We explored lessons and successes from the FP experience to identify how FP/SRH stakeholders can help pave the way for smooth introduction of MPTs like the DPP in private sector channels.
Avac Event
PrEPWatch is a one-stop online clearinghouse for resources and information to help the global community effectively deliver every proven method of PrEP to everyone who needs it. This webinar explored the newly relaunched site and walked through some of the latest features including better-than-ever curation, navigation, and search. We heard from leading advocates on what’s in the pipeline for prevention products and trends happening in PrEP uptake and delivery.
Avac Event
Join us for a conversation with The London Patient, Adam Castillejo — only the second person cured of HIV. He will share his experience with the procedure that ultimately eradicated HIV from his body, why people should be hopeful about the state of the research, and what his life is like after HIV. Attendees will be able to ask questions and take photos with Adam after the event.
Avac Event
Africa Health R&D Week 2022 is designed to recognize achievements and step up advocacy for sustainable financing of health R&D through domestic resource mobilization (DRM) in Africa. The week contains a series of informative, networking, and motivational events for advocates, media, policymakers, program implementors, researchers, and funders to bring clarity to key issues and trends of DRM for health R&D on the continent. The content and programming of Africa Health R&D Week is informed by the various coalitions advocating for DRM for health.
Speakers:
Agenda / Concept Note / Flyers